Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 496 | -67,089 | -17,133 | 39,141 | 89,136 |
| Depreciation Amortization | 1,127 | -6,174 | -4,882 | -2,411 | -383 |
| Accounts receivable | -1,397 | -32,698 | -22,516 | -42,407 | -17,339 |
| Accounts payable and accrued liabilities | -6,044 | 2,197 | N/A | 231 | 313 |
| Other Working Capital | -38,346 | -64,685 | -54,547 | -70,011 | -43,203 |
| Other Operating Activity | -10,315 | -24,137 | -64,144 | -74,128 | -130,037 |
| Operating Cash Flow | $-54,479 | $-192,586 | $-163,222 | $-149,585 | $-101,513 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,827 | -42,871 | -77,512 | -107,488 | 78,235 |
| PPE Investments | -1,831 | -4,630 | -3,698 | -3,673 | -1,104 |
| Sale Of Investment | 78,737 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $65,079 | $-47,501 | $-81,210 | $-111,161 | $77,131 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 146,973 | 146,973 | 146,973 | N/A |
| Debt Repayment | -4,106 | -541 | -541 | -541 | -369 |
| Common Stock Issued | 13,298 | 77,743 | 67,984 | 49,607 | 67,332 |
| Other Financing Activity | 0 | 48,936 | 48,936 | 48,936 | 0 |
| Financing Cash Flow | $9,192 | $273,111 | $263,352 | $244,975 | $66,963 |
| Exchange Rate Effect | 661 | -909 | 415 | -176 | -145 |
| Beginning Cash Position | 113,639 | 81,524 | 81,524 | 81,524 | 81,524 |
| End Cash Position | 134,092 | 113,639 | 100,859 | 65,577 | 123,960 |
| Net Cash Flow | $20,453 | $32,115 | $19,335 | $-15,947 | $42,436 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,479 | -192,586 | -163,222 | -149,585 | -101,513 |
| Capital Expenditure | -1,831 | -4,630 | -3,698 | -3,673 | -1,104 |
| Free Cash Flow | -56,310 | -197,216 | -166,920 | -153,258 | -102,617 |